Physician profile
Megan A Settle
NPI 1578829594
$8,484.86
in general payments reported to CMS, 2019-2025
44 companies · $1,977 in 2025
The $1,977 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $875 · 2021: $864 · 2022: $959 · 2023: $1,559 · 2024: $1,958 · 2025: $1,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,396 · Education: $98.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,395.77 |
| Education | $98.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,420.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,387.94 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Pfizer INC. | $713.26 | 2021-2025 | |
| Lilly USA, LLC | $666.09 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $634.46 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Astellas Pharma US INC | $463.60 | 2020-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $396.37 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Exact Sciences Corporation | $319.89 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $257.25 | 2019-2025 | Xarelto, Spravato |
| Glaxosmithkline, LLC. | $226.89 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Allergan, INC. | $224.65 | 2020 | |
| Abbott Laboratories | $177.03 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Alkermes, INC. | $163.50 | 2022-2024 | Vivitrol, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $162.15 | 2023-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.52 | 2025 | Caplyta |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Settle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.